1. Home
  2. IKT vs EVTL Comparison

IKT vs EVTL Comparison

Compare IKT & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.70

Market Cap

240.1M

Sector

Health Care

ML Signal

HOLD

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$2.44

Market Cap

233.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IKT
EVTL
Founded
2008
2016
Country
United States
United Kingdom
Employees
N/A
454
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
240.1M
233.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
IKT
EVTL
Price
$1.70
$2.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$5.00
$12.50
AVG Volume (30 Days)
1.2M
3.3M
Earning Date
03-26-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
57.76
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$33.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$1.90
52 Week High
$2.37
$7.60

Technical Indicators

Market Signals
Indicator
IKT
EVTL
Relative Strength Index (RSI) 46.70 36.54
Support Level $1.43 $1.90
Resistance Level $1.74 $4.80
Average True Range (ATR) 0.11 0.32
MACD -0.00 0.05
Stochastic Oscillator 59.62 33.23

Price Performance

Historical Comparison
IKT
EVTL

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

Share on Social Networks: